Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
研究概览
地位
详细说明
Previous studies have demonstrated reliable myocardial protection with Del Nido cardioplegia; however, most comparisons with conventional blood cardioplegia are based on biochemical markers (troponin, CK-MB) and echocardiography. Cardiac magnetic resonance imaging (CMR) enables noninvasive, highly sensitive assessment of left ventricular function as well as myocardial viability, edema, and fibrosis, and represents the gold standard for the evaluation of ventricular volumes and ejection fraction. To date, this imaging modality has not been used as a method for comparing different myocardial protection strategies in the context of various cardioplegic solutions.
The study will include patients with isolated coronary artery disease who are scheduled for surgical myocardial revascularization. Exclusion criteria will include the need for concomitant valve, aortic, or other cardiac surgery, as well as patients planned for myocardial revascularization without the use of cardiopulmonary bypass. Additionally, patients with contraindications to CMR will be excluded from the study.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Hrvoje Gasparovic, MD, PhD
- 电话号码:+385 1 236 7529
- 邮箱:hrvoje.gasparovic@kbc-zagreb.hr
学习地点
-
-
-
Zagreb、克罗地亚、10000
- 招聘中
- University Hospital Center Zagreb
-
接触:
- Hrvoje Gasparovic, MD, PhD
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Eligibility Criteria:
1. Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting
Exclusion Criteria:
- Left ventricular ejection fraction <30%
- Associated cardiac procedures
- Off-pump coronary artery bypass grafting
- Contraindications for MRI
- Inability to provide consent
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Del Nido cardioplegia
CABG patients receiving Del Nido cardioplegia as the myocardial protection strategy
|
CABG patients receiving Del Nido cardioplegia as the myocardial protection strategy
|
|
有源比较器:Blood cardioplegia
CABG patients receiving blood cardioplegia as the myocardial protection strategy
|
Patients will receive Blood Cardioplegia Solution for myocardial protection
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Myocardial Viability Assessed by Magnetic Resonance Imaging
大体时间:Patients will undergo the initial cardiac MRI scan before surgery. The follow-up MRI will be scheduled approximately 4 weeks after surgical revascularization.
|
Myocardial Viability Assessed by Magnetic Resonance Imaging
|
Patients will undergo the initial cardiac MRI scan before surgery. The follow-up MRI will be scheduled approximately 4 weeks after surgical revascularization.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Major Adverse Cardiac and Cerebrovascular Events
大体时间:MACCE will be adjudicated at 30 days and 6 months.
|
The secondary outcome will be a composite of mortality, periprocedural myocardial infarction, stroke, and cardiac rehospitalization
|
MACCE will be adjudicated at 30 days and 6 months.
|
合作者和调查者
调查人员
- 首席研究员:Hrvoje Gasparovic、Clinical Hospital Centre Zagreb
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.